Adaptive Biotechnologies's Comment on Supply Chain
The company depends on suppliers, including single-source suppliers, for laboratory equipment and materials. To mitigate concentration risk, it maintains surplus stock to provide time for sourcing alternative suppliers if necessary. One key supplier is Illumina, Inc., which supplies the Illumina NextSeq and NovaSeq X Plus systems along with reagents specifically designed for use with these sequencers. Replacing these reagents would necessitate acquiring and validating new sequencers and assays, potentially resulting in delays and increased costs.
Adaptive Biotechnologies's Comment on Supply Chain
The company depends on suppliers, including single-source suppliers, for laboratory equipment and materials. To mitigate concentration risk, it maintains surplus stock to provide time for sourcing alternative suppliers if necessary. One key supplier is Illumina, Inc., which supplies the Illumina NextSeq and NovaSeq X Plus systems along with reagents specifically designed for use with these sequencers. Replacing these reagents would necessitate acquiring and validating new sequencers and assays, potentially resulting in delays and increased costs.
Sources:
Adaptive Biotechnologies Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Adaptive Biotechnologies Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
